HLA-C and acute myeloid leukemia: Hematopoietic stem cells/Leukemia stem cells, AML with CEBPA mutation, AML with FLT3‐internal tandem duplication mutation, TALL1 pathway, and MHC pathway, apoptosis were enriched in the high‐risk group (Figure 6B).